CD8A and renal cell carcinoma: This gene expression-based cell type enrichment analysis revealed that CD8 T cell populations were significantly reduced in PBRM1 mutated tumors in TCGA, IMmotion150 and ICGC RCC cohorts (Fig. 4e).